ReviewObstetrics & gynecology science2025
Vaginal microbiome and its implications in preterm birth.
Review in Obstetrics & gynecology science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Vaginal microbiome composition in pregnant and non-pregnant women: community structure, population variation, clinical impact, and metagenomics approaches.Infection and immunity · 2026Review
- The Maternal Microbiome in Pregnancy: From Physiological Changes to Dysbiosis and Obstetrical Complications-Therapeutic Perspectives.Life (Basel, Switzerland) · 2026Review
- Small Vesicles Big Impact: Exosomes in the Landscape of Women's Health.Pharmaceutical research · 2026Review
- The neutrophil-to-lymphocyte ratio: a marker for microbial invasion of the amniotic cavity in preterm prelabor rupture of membranes.Obstetrics & gynecology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Preterm birth (PTB), defined as birth occurring before 37 weeks of gestation, remains a major global public health challenge, affecting approximately 10% of pregnancies worldwide and contributing significantly to neonatal morbidity and mortality. Despite extensive research, the etiology of PTB is multifactorial and not yet fully understood, with ongoing debates regarding the contributions of inflammation, hormonal dysregulation, genetic predisposition, and environmental factors such as microbial dysbiosis. Recent studies have highlighted the role of the vaginal microbiome in pregnancy outcomes, particularly its association with PTB. This review consolidates current findings on the vaginal microbiome's influence on PTB, addressing microbial dysbiosis as a key risk factor. Despite differences in ethnicity, gestational age at sample collection, and analytical methodologies, a common observation is that a decrease in Lactobacillus species is associated with an increased risk of PTB. These differences influence study outcomes by affecting variations in microbial composition, host immune regulation, genetic predisposition, and environmental influences. However, a consistently observed trend is that a Lactobacillus-dominant vaginal microbiome is generally associated with a lower risk of PTB across diverse populations. This review also discusses the limitations of existing research and suggests directions for future microbiome studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.